Parkinson’s Treatment: Disease Modifying vs. Symptomatic | 2019 Udall Center Research Symposium

(34:48)

WHEN to upgrade an MS disease modifying therapy [all 5 reasons]

(5:23)

Disease-modifying gene therapies for common epilepsies

(1:3)

Guidelines for Disease-Modifying Therapy in MS

(4:39)

Introduction to Antirheumatics (DMARDs)

(5:55)

Rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology

(12:28)

Doctor Thinks He Knows What Causes Alzheimer’s, Parkinson’s, and ALS! | Mark Hyman

(56:35)

TELOGEN EFFLUVIUM RECOVERY | WHAT WORKED FOR ME | NO B.S. HAIR REGROWTH TIPS | LAUREN NEWLY

(8:44)

Multiple Sclerosis | Etiology, Pathophysiology, Types of MS, Clinical Features, Diagnosis, Treatment

(54:15)

DRESS Syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms)

(7:17)

Tecfidera Side Effects

(9:19)

Saving Florida’s oranges, one stomach hole at a time

(2:43)

Multiple sclerosis - causes, symptoms, diagnosis, treatment, pathology

(11:16)

Plant Based Nutrition: What, Why, How?

(55:14)

Rheumatoid Arthritis - Guidelines and Paradigms

(31:13)

AAN Releases Guideline: Disease-modifying Therapies for Adults with Multiple Sclerosis

(20:42)

Patellofemoral Pain Syndrome (Runner’s Knee): Causes, Symptoms \u0026 Effective Exercises for Knee Pain

(12:26)

Is My Disease Modifying Therapy Working? - National MS Society

(1:35)

Scientist Explains: Disease Modifying Agents in Dementia

(4:48)

Disease Modifying Medication

(8:16)

Disease modifying anti-rheumatic drugs (DMARDs)

(3:47)

Disease-modifying antirheumatic drugs (DMARDs) Part 1 - Pharmacology

(9:48)

Disease Modifying Therapy for MS: When to Dump Your MS Drug

(3:56)

NMOSD: Disease Modifying Therapies [2024 Update]

(16:46)

A PNI Minute | Disease Modifying Therapies (DMTs) for the treatment of Multiple Sclerosis

(2:15)

Will asks the expert about disease modifying drugs

(15:3)

The challenges in disease-modifying therapy development in Parkinson’s disease

(1:31)

Ask the expert: disease modifying drugs

(9:57)

How disease-modifying agents may impact the role of transplantation in patients with MF

(2:15)